ARDENT HEALTH PARTNERS INC (ARDT)

US03980N1072 - Common Stock

13.8  -0.25 (-1.78%)

After market: 13.8 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
4.87B5.13B
5.32%		5.409B
5.45%		5.961B
10.20%		6.428B
7.83%		6.816B
6.04%
EBITDA
YoY % growth
440.377M338.426M
-23.15%		356.685M
5.40%		467.3M
31.01%		654.88M
40.14%		734.24M
12.12%
EBIT
YoY % growth
303.173M200.253M
-33.95%		215.843M
7.79%		363.12M
68.23%		536.81M
47.83%		601.35M
12.02%
Operating Margin
6.22%3.90%3.99%6.09%8.35%8.82%
EPS
YoY % growth
N/AN/AN/A1.242.04
63.98%		2.31
13.47%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.470.400.56
65.40%		0.48
182.90%		0.58
24.96%		0.46
15.00%		0.64
13.24%		0.55
13.40%		0.68
15.88%
Revenue
Q2Q % growth		1.512B1.56B
8.41%		1.623B
10.34%		1.604B
10.63%		1.647B
8.93%		1.656B
6.15%		1.725B
6.28%		1.7B
5.99%		1.746B
6.01%
EBITDA
Q2Q % growth		129.88M137.71M
23.87%		172.59M
-0.61%		156.63M
-12.41%		178M
37.05%		152.52M
10.75%		188.77M
9.37%		176.6M
12.75%		199.95M
12.33%
EBIT
Q2Q % growth		107.5M110.61M
45.88%		146.01M
43.17%		127.47M
81.12%		149.06M
38.66%		129.9M
17.44%		168.45M
15.37%		150.09M
17.75%		174.37M
16.98%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 0.17 0.31-0.14-44.28%
Q2 2024
Q2Q % growth		 0.34 0.310.0310.01%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 1.45B 1.481B-31.183M-2.11%
Q2 2024
Q2Q % growth		 1.471B 1.487B-16.08M-1.08%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 0.47% N/A
Revenue0% N/A 0.03% N/A